484 related articles for article (PubMed ID: 18191066)
1. Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus.
Danne T
Clin Ther; 2007; 29 Suppl D():S145-52. PubMed ID: 18191066
[TBL] [Abstract][Full Text] [Related]
2. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
3. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
4. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
Bolli GB
Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
[TBL] [Abstract][Full Text] [Related]
5. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
Kinsley B
Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
[TBL] [Abstract][Full Text] [Related]
6. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
8. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
Rolla AR; Rakel RE
Clin Ther; 2005 Aug; 27(8):1113-25. PubMed ID: 16199240
[TBL] [Abstract][Full Text] [Related]
9. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
[TBL] [Abstract][Full Text] [Related]
10. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
12. Diversity in diabetes: the role of insulin aspart.
Heller S; McCance DR; Moghissi E; Nazeri A; Kordonouri O
Diabetes Metab Res Rev; 2012 Jan; 28(1):50-61. PubMed ID: 21695769
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
Bolli GB
Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
[TBL] [Abstract][Full Text] [Related]
14. Getting closer to physiologic insulin secretion.
Heise T
Clin Ther; 2007; 29 Suppl D():S161-5. PubMed ID: 18191068
[TBL] [Abstract][Full Text] [Related]
15. Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.
Cucinotta D; Russo GT
Expert Opin Pharmacother; 2009 Dec; 10(17):2905-11. PubMed ID: 19929709
[TBL] [Abstract][Full Text] [Related]
16. Rediscovery of insulin pump treatment of childhood type 1 diabetes.
Weinzimer SA; Doyle EA; Steffen AT; Sikes KA; Tamborlane WV
Minerva Med; 2004 Apr; 95(2):85-92. PubMed ID: 15272243
[TBL] [Abstract][Full Text] [Related]
17. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
18. Premixed insulin treatment for type 2 diabetes: analogue or human?
Garber AJ; Ligthelm R; Christiansen JS; Liebl A
Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
[TBL] [Abstract][Full Text] [Related]
19. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
20. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
